1. Sivakumaar, Krithicck, Griffin, Jon, Schofield, Ella, Catto, James W F, Jubber, Ibrahim. 2024. Gene of the month: the uroplakins. In Journal of clinical pathology, 77, 291-296. doi:10.1136/jcp-2024-209388. https://pubmed.ncbi.nlm.nih.gov/38418202/
2. Chicote, Javier U, DeSalle, Rob, Segarra, José, Sun, Tung-Tien, García-España, Antonio. 2017. The Tetraspanin-Associated Uroplakins Family (UPK2/3) Is Evolutionarily Related to PTPRQ, a Phosphotyrosine Phosphatase Receptor. In PloS one, 12, e0170196. doi:10.1371/journal.pone.0170196. https://pubmed.ncbi.nlm.nih.gov/28099513/
3. Äijälä, Ville K, Härkönen, Jouni, Mantere, Tuomo, Mäkinen, Markus J, Väyrynen, Juha P. 2025. Comprehensive characterization of micropapillary colorectal adenocarcinoma. In The Journal of pathology, 265, 408-421. doi:10.1002/path.6392. https://pubmed.ncbi.nlm.nih.gov/39917902/
4. Zhu, Ji, Lu, Qijue, Li, Bin, Li, Chunguang, Jin, Hai. 2021. Potential of the cell-free blood-based biomarker uroplakin 2 RNA to detect recurrence after surgical resection of lung adenocarcinoma. In Oncology letters, 22, 520. doi:10.3892/ol.2021.12781. https://pubmed.ncbi.nlm.nih.gov/34025787/
5. Yee, Christopher H, Zheng, Zongyu, Shuman, Lauren, Raman, Jay D, DeGraff, David J. 2019. Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS. In Scientific reports, 9, 270. doi:10.1038/s41598-018-36720-6. https://pubmed.ncbi.nlm.nih.gov/30670749/
6. Olkhov-Mitsel, Ekaterina, Yu, Yanhong, Lajkosz, Katherine, Sherman, Christopher G, Downes, Michelle R. 2022. Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification. In Cancers, 14, . doi:10.3390/cancers14194911. https://pubmed.ncbi.nlm.nih.gov/36230835/
智鼠故事 
